A recent study has provided a new insight into the molecular mechanism underlying the anti-inflammatory effect of FBP1, a high-energy intermediate of glycolysis, in effectively attenuating experimental arthritis [57]. This evidence concerns the gene FBP1 and arthritic joint disease.